People · Operator
Named in public records as an officer, director or promoter · active 2011–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prime Genomics, Inc. | — | Biotechnology | Pre-Seed | $1.3M | $44.4M | 2011 |
SCOTT R. GREENSTONE at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside SCOTT R. GREENSTONE on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ROBERT R. TUFTS | 1 | 9 |
| PETER V. GROETZINGER | 1 | 1 |
| SANDY C. SHAW | 1 | 1 |
| ALAN R. BRIMM | 1 | 1 |
| THOMAS W LOKER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.